163 related articles for article (PubMed ID: 3816509)
1. A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats.
Goto J; Araki H; Otomo S; Aihara H
Drugs Exp Clin Res; 1986; 12(11):917-21. PubMed ID: 3816509
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E1 incorporated in lipid microspheres (lipo PGE1).
Otomo S; Mizushima Y; Aihara H; Yokoyama K; Watanabe M; Yanagawa A
Drugs Exp Clin Res; 1985; 11(9):627-31. PubMed ID: 3880049
[TBL] [Abstract][Full Text] [Related]
3. Treatment of established collagen induced arthritis with prostaglandin E1 incorporated in lipid microspheres.
Moriuchi-Murakami E; Yamada H; Ishii O; Kikukawa T; Igarashi R
J Rheumatol; 2000 Oct; 27(10):2389-96. PubMed ID: 11036835
[TBL] [Abstract][Full Text] [Related]
4. Effect of isocarbacyclin methyl ester incorporated in lipid microspheres on experimental models of peripheral obstructive disease.
Murakami T; Sawada K; Taneda K; Hayashi M; Katsuura Y; Tanabe H; Kiyoki M; Araki H
Arzneimittelforschung; 1995 Sep; 45(9):991-4. PubMed ID: 7488320
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.
Hoshi K; Mizushima Y; Kiyokawa S; Yanagawa A
Drugs Exp Clin Res; 1986; 12(8):681-5. PubMed ID: 3757764
[TBL] [Abstract][Full Text] [Related]
6. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders.
Mizushima Y; Shiokawa Y; Homma M; Kashiwazaki S; Ichikawa Y; Hashimoto H; Sakuma A
J Rheumatol; 1987 Feb; 14(1):97-101. PubMed ID: 3553591
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of alprostadil (prostaglandin E1) incorporated in lipid microspheres of soybean oil on intimal hyperplasia following balloon injury in rabbits.
Kunihara M; Tsuchida K; Kaneko K; Suga H; Hasegawa T; Mochizuki S; Kawai K; Shiga A; Yamaguchi T
Arzneimittelforschung; 2002; 52(5):358-64. PubMed ID: 12087920
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
[TBL] [Abstract][Full Text] [Related]
9. The effect of prostaglandin E1 incorporated in lipid microspheres on thrombus formation and thrombus disaggregation and its potential to target to the site of vascular lesions.
Sim AK; McCraw AP; Cleland ME; Aihara H; Otomo S; Hosoda K
Arzneimittelforschung; 1986 Aug; 36(8):1206-9. PubMed ID: 3778557
[TBL] [Abstract][Full Text] [Related]
10. Review: recent advances in lipid microsphere technology for targeting prostaglandin delivery.
Mizushima Y; Hoshi K
J Drug Target; 1993; 1(2):93-100. PubMed ID: 8069557
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of prostaglandin E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits: optimized topical formulation with beta-cyclodextrin derivative and penetration enhancer HPE-101.
Adachi H; Irie T; Uekama K; Manako T; Yano T; Saita M
J Pharm Pharmacol; 1992 Dec; 44(12):1033-5. PubMed ID: 1361553
[TBL] [Abstract][Full Text] [Related]
12. Interaction between non-ionic contrast medium and prostaglandin E1 incorporated in lipid microspheres: in-vitro comparative study of direct and non-direct mixing.
Hayashi H; Uchiyama N; Kawamata H; Takagi R; Abe Y; Kumazaki T
Radiat Med; 2000; 18(4):219-25. PubMed ID: 11246996
[TBL] [Abstract][Full Text] [Related]
13. [Studies on antinephritic effect of Lipo PGE1 (2). The suppressive action of Lipo PGE1 on the development of accelerated passive Heymann nephritis in rats].
Nagao T; Ito M; Suzuki Y
Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1071-9. PubMed ID: 1725534
[TBL] [Abstract][Full Text] [Related]
14. [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders].
Heidrich H
Vasa Suppl; 1991; 33():346-7. PubMed ID: 1788752
[TBL] [Abstract][Full Text] [Related]
15. Vasodilating effect and tissue accumulation of prostaglandin E1 incorporated in lipid microspheres on the rat ductus arteriosus.
Chino Y; Minagawa T; Kohno Y; Fukushima K; Momma K
Jpn J Pharmacol; 1999 Sep; 81(1):107-14. PubMed ID: 10580378
[TBL] [Abstract][Full Text] [Related]
16. [Studies on antinephritic effect of lipo PGE1 (1). Effect of lipo PGE1 on crescentic-type anti-GBM nephritis in rats].
Nagao T; Hattori T; Ito M; Suzuki Y
Nihon Jinzo Gakkai Shi; 1991 Mar; 33(3):247-56. PubMed ID: 2062010
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and hemodynamic effects of lipo PGE1 in cerebral infarction].
Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
No Shinkei Geka; 1988 Jun; 16(7):819-26. PubMed ID: 3221965
[TBL] [Abstract][Full Text] [Related]
18. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
Toyota T; Hirata Y; Ikeda Y; Matsuoka K; Sakuma A; Mizushima Y
Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
[TBL] [Abstract][Full Text] [Related]
19. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
[TBL] [Abstract][Full Text] [Related]
20. Lipo-PGE1, prostaglandin E1 incorporated in lipid microspheres, protects injury of the liver caused by warm ischemia reperfusion.
Egashira T; Kim YI; Takayama F; Kudo Y; Yamanaka Y
Free Radic Biol Med; 1996; 21(3):353-6. PubMed ID: 8855446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
